- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
100
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
100 companies
Klaria Pharma Holding AB (publ.)
Market Cap: SEK 113.1m
A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.
KLAR
SEK 0.46
7D
-9.1%
1Y
11.9%
Caliway Biopharmaceuticals
Market Cap: NT$192.3b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$124.00
7D
-9.5%
1Y
141.7%
Shanghai Rightongene Biotechnology
Market Cap: CN¥1.6b
Shanghai Rightongene Biotechnology Co., Ltd.
688217
CN¥29.84
7D
3.9%
1Y
38.3%
Solara Active Pharma Sciences
Market Cap: ₹27.6b
Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.
SOLARA
₹572.95
7D
1.4%
1Y
-24.4%
Oryzon Genomics
Market Cap: €241.7m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system) disorders.
ORY
€3.07
7D
-6.6%
1Y
84.9%
Diamyd Medical
Market Cap: SEK 1.4b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 9.89
7D
-3.2%
1Y
-20.8%
BioRestorative Therapies
Market Cap: US$11.5m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.33
7D
-2.9%
1Y
-8.3%
TriSalus Life Sciences
Market Cap: US$227.8m
Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.
TLSI
US$4.56
7D
3.9%
1Y
16.0%
Krystal Biotech
Market Cap: US$6.0b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$206.16
7D
4.2%
1Y
20.7%
AcrobiosystemsLtd
Market Cap: CN¥10.4b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
301080
CN¥62.03
7D
3.7%
1Y
90.4%
BrightGene Bio-Medical Technology
Market Cap: CN¥23.2b
Engages in the research, development, production, and sale of pharmaceutical products in China and internationally.
688166
CN¥54.85
7D
3.1%
1Y
75.7%
Nanjing Leads Biolabs
Market Cap: HK$11.7b
A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.
9887
HK$59.00
7D
0.9%
1Y
n/a
Journey Medical
Market Cap: US$214.1m
Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$7.89
7D
-13.4%
1Y
52.9%
ImmunityBio
Market Cap: US$2.0b
A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.
IBRX
US$2.08
7D
-2.3%
1Y
-53.7%
InnoCare Pharma
Market Cap: HK$29.1b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$15.17
7D
8.4%
1Y
121.5%
IRLAB Therapeutics
Market Cap: SEK 197.1m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 2.32
7D
-3.3%
1Y
-83.4%
CanSino Biologics
Market Cap: HK$15.5b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$46.00
7D
4.8%
1Y
58.9%
Protalix BioTherapeutics
Market Cap: US$149.6m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$1.86
7D
-15.1%
1Y
32.9%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł260.4m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł47.10
7D
4.7%
1Y
-14.7%
Changchun BCHT Biotechnology
Market Cap: CN¥9.8b
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.
688276
CN¥23.77
7D
9.1%
1Y
-10.2%
Clene
Market Cap: US$85.8m
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN
US$8.52
7D
-12.9%
1Y
88.1%
PYC Therapeutics
Market Cap: AU$799.1m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$1.37
7D
17.6%
1Y
-25.9%
ApicHope Pharmaceutical Group
Market Cap: CN¥23.1b
Engages in the research and development, production, and sale of pharmaceutical drugs.
300723
CN¥51.42
7D
5.2%
1Y
208.6%
Formycon
Market Cap: €366.5m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€20.75
7D
7.5%
1Y
-55.2%
Harrow
Market Cap: US$1.5b
An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
HROW
US$40.79
7D
20.2%
1Y
4.6%
Dyadic International
Market Cap: US$33.0m
A biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally.
DYAI
US$0.91
7D
-2.4%
1Y
-19.2%
Guard Therapeutics International
Market Cap: SEK 28.9m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 1.44
7D
-2.0%
1Y
-93.1%
Telix Pharmaceuticals
Market Cap: AU$4.8b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$14.13
7D
-5.9%
1Y
-38.3%
Beijing Konruns PharmaceuticalLtd
Market Cap: CN¥7.6b
Engages in the research and development, production, and sale of pharmaceuticals in China and internationally.
603590
CN¥47.42
7D
3.5%
1Y
97.2%
Lipum
Market Cap: SEK 232.3m
A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.
LIPUM
SEK 10.95
7D
-13.8%
1Y
-24.0%
Celcuity
Market Cap: US$4.3b
A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
CELC
US$92.68
7D
24.4%
1Y
632.1%
Aprea Therapeutics
Market Cap: US$7.0m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.21
7D
-1.6%
1Y
-62.8%
Inner Mongolia Furui Medical Science
Market Cap: CN¥19.0b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥71.53
7D
-8.1%
1Y
91.1%
Sai Life Sciences
Market Cap: ₹183.0b
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.
SAILIFE
₹871.95
7D
-0.4%
1Y
n/a
Niagen Bioscience
Market Cap: US$550.2m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$6.87
7D
0.4%
1Y
0.7%
Abeona Therapeutics
Market Cap: US$241.2m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$4.45
7D
6.0%
1Y
-24.1%